Amoxicillin - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for amoxicillin and what is the scope of freedom to operate?
Amoxicillin
is the generic ingredient in twenty-five branded drugs marketed by Aurobindo, Chartwell, Hikma Pharms, Labs Atral, Micro Labs, Mylan, Sandoz, Strides Pharma, Sun Pharm Inds Ltd, Teva, Glaxosmithkline, Us Antibiotics, Apothecon, Parke Davis, Wyeth Ayerst, Aurobindo Pharma Ltd, Chartwell Rx, Endo Operations, Hikma, Pragma, Ranbaxy Labs Ltd, Ani Pharms, Rising, Takeda Pharms Usa, Cumberland, Phathom, Aurobindo Pharma, Cipla, Deva Holding As, Micro Labs Ltd India, Sandoz Inc, Apotex Inc, Teva Pharms Usa, and Redhill, and is included in one hundred and twenty-six NDAs. There are twelve patents protecting this compound. Additional information is available in the individual branded drug profile pages.Amoxicillin has eleven patent family members in six countries.
There are forty-six drug master file entries for amoxicillin. Thirty-six suppliers are listed for this compound.
Summary for amoxicillin
International Patents: | 11 |
US Patents: | 12 |
Tradenames: | 25 |
Applicants: | 34 |
NDAs: | 126 |
Drug Master File Entries: | 46 |
Finished Product Suppliers / Packagers: | 36 |
Raw Ingredient (Bulk) Api Vendors: | 68 |
Clinical Trials: | 581 |
Patent Applications: | 6,473 |
Drug Prices: | Drug price trends for amoxicillin |
Drug Sales Revenues: | Drug sales revenues for amoxicillin |
What excipients (inactive ingredients) are in amoxicillin? | amoxicillin excipients list |
DailyMed Link: | amoxicillin at DailyMed |
Recent Clinical Trials for amoxicillin
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Rutgers, The State University of New Jersey | Phase 3 |
National Institute of Dental and Craniofacial Research (NIDCR) | Phase 3 |
National Dental PBRN | Phase 3 |
Pharmacology for amoxicillin
Drug Class | Penicillin-class Antibacterial |
Medical Subject Heading (MeSH) Categories for amoxicillin
Anatomical Therapeutic Chemical (ATC) Classes for amoxicillin
US Patents and Regulatory Information for amoxicillin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz | AMOXICILLIN | amoxicillin | TABLET;ORAL | 065228-002 | Jul 13, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hikma Pharms | AMOXICILLIN AND CLAVULANATE POTASSIUM | amoxicillin; clavulanate potassium | FOR SUSPENSION;ORAL | 065191-002 | Jan 25, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Teva | AMOXICILLIN AND CLAVULANATE POTASSIUM | amoxicillin; clavulanate potassium | TABLET, CHEWABLE;ORAL | 065205-001 | Feb 9, 2005 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Apotex Inc | AMOXICILLIN AND CLAVULANATE POTASSIUM | amoxicillin; clavulanate potassium | TABLET;ORAL | 065317-003 | Oct 20, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for amoxicillin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pragma | MOXATAG | amoxicillin | TABLET, EXTENDED RELEASE;ORAL | 050813-001 | Jan 23, 2008 | ⤷ Sign Up | ⤷ Sign Up |
Pragma | MOXATAG | amoxicillin | TABLET, EXTENDED RELEASE;ORAL | 050813-001 | Jan 23, 2008 | ⤷ Sign Up | ⤷ Sign Up |
Pragma | MOXATAG | amoxicillin | TABLET, EXTENDED RELEASE;ORAL | 050813-001 | Jan 23, 2008 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for amoxicillin
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 1968586 | COMPOSITIONS PHARMACEUTIQUES ET MÉTHODES POUR ÉRADICATION BACTÉRIENNE AMÉLIORÉE (PHARMACEUTICAL COMPOSITIONS AND METHODS FOR IMPROVED BACTERIAL ERADICATION) | ⤷ Sign Up |
China | 101563466 | Modified release amoxicillin products | ⤷ Sign Up |
Australia | 2006351475 | Modified release amoxicillin products | ⤷ Sign Up |
Japan | 2010511607 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.